Indivior Pharmaceuticals (INDV) Operating Income (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Operating Income of $137.0 million for Q1 2026, up 107.58% year-over-year from $66.0 million in Q1 2025, and up 69.14% quarter-over-quarter from $81.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Operating Income (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Operating Income history runs 3 years deep, the most recent figure standing at $137.0 million for Q1 2026.
- In Q1 2026, Operating Income rose 107.58% year-over-year to $137.0 million; the TTM figure through Mar 2026 stood at $333.0 million (up 1048.28% YoY), while the FY2025 annual figure was $262.0 million, up 589.47% from the prior year.
- Operating Income for Q1 2026 stood at $137.0 million, up from $81.0 million in the prior quarter.
- The five-year high for Operating Income was $137.0 million in Q1 2026, with the low at -$118.0 million in Q2 2024.
- The 3-year median for Operating Income is $66.0 million (2025), against an average of $48.6 million.
- Peak annual rise in Operating Income reached 161.02% in 2025, while the deepest fall reached 12.0% in 2025.
- Indivior Pharmaceuticals' Operating Income stood at $46.0 million in 2024, then jumped by 76.09% to $81.0 million in 2025, then jumped by 69.14% to $137.0 million in 2026.
- Business Quant data shows INDV's Operating Income at $137.0 million in Q1 2026, $81.0 million in Q4 2025, and $43.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.59 Bn | 4.37 Bn | 294.00 Mn | 160.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 160.00 Mn |
| Mar 31, 2026 | 137.00 Mn |
| Dec 31, 2025 | 81.00 Mn |
| Sep 30, 2025 | 43.00 Mn |
| Jun 30, 2025 | 72.00 Mn |
| Mar 31, 2025 | 66.00 Mn |
| Dec 31, 2024 | 46.00 Mn |
| Sep 30, 2024 | 35.00 Mn |
| Jun 30, 2024 | -118.00 Mn |
| Mar 31, 2024 | 75.00 Mn |